Infectociprocort

Ciprofloxacin, the active ingredient in Infectociprocort, is a fluoroquinolone antibiotic presented as a topical ear preparation for auricular use. Combined with the corticosteroid fluocinolone acetonide, it treats bacterial ear infections and reduces inflammation in patients with external otitis and related conditions.

GNH USA supplies Infectociprocort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infectociprocort acts on bacterial and inflammatory pathways in the external ear. - External otitis: eliminates causative bacteria and lessens canal inflammation. - Bacterial otitis externa: provides broad‑spectrum antibacterial coverage while soothing swelling. - Ear inflammation with infection: delivers combined antimicrobial and anti‑inflammatory action to improve symptoms and promote healing.

Infectociprocort may cause local and systemic reactions.

Common Side Effects: - Ear discomfort or mild burning sensation. - Itching or irritation at the application site. - Temporary alteration in hearing perception. - Mild headache. - Local redness or swelling. - Dryness of the ear canal.

Serious or Rare Side Effects: - Allergic reaction with rash, swelling, or difficulty breathing. - Ototoxicity leading to permanent hearing loss. - Severe ear pain or ulceration. - Vestibular disturbances such as dizziness or vertigo. - Secondary fungal or bacterial infection of the ear. - Systemic hypersensitivity including fever and joint pain.

Use Infectociprocort only as prescribed and observe the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: consider potential exposure to the infant. - Age: limit use in children unless directed by a physician. - Perforated tympanic membrane: avoid application if the eardrum is ruptured. - Concurrent ototoxic drugs: monitor for additive ear toxicity. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Infectociprocort can interact with other medicines; awareness of these interactions helps maintain safety.

Major Interactions (Avoid): - Systemic fluoroquinolones: increased risk of tendon rupture. - Ototoxic agents (e.g., aminoglycosides): additive ear toxicity. - Systemic corticosteroids: may enhance systemic steroid effects.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: heightened risk of gastrointestinal irritation. - Warfarin: possible increase in INR and bleeding risk.